Parameter | FASa (N = 600) |
---|---|
Demographics | |
 Age, years | |
  Mean (SD) | 54.3 (12.9) |
  Median (IQR) | 55.0 (45.0–63.5) |
 Sex, n (%) | |
  Male | 403 (67.2) |
Disease characteristics and concomitant conditions | |
 Aetiology of ESRD, n (%) | |
  Primary glomerulonephritis | 188 (38.8) |
  Diabetic kidney disease | 135 (27.8) |
  Hypertensive renal disease | 77 (15.9) |
 Any medical historyb, n (%) | 599 (99.8) |
  Hyperkalaemia | 360 (60.0) |
  Renal anaemia | 487 (81.2) |
  Hypertension | 487 (81.2) |
  Hyperphosphataemia | 277 (46.2) |
  Diabetes mellitus | 119 (19.8) |
  Metabolic acidosis | 79 (13.2) |
  Hyperlipidaemia | 75 (12.5) |
  Coronary artery disease | 75 (12.5) |
  Hyperuricaemia | 61 (10.2) |
Dialysis parameters | |
 Type of haemodialysis, n (%) | |
  Haemodialysis | 529 (88.3) |
  Haemodiafiltration | 60 (10.0) |
  Haemoperfusion combined with haemodialysis or haemodiafiltration | 10 (1.7) |
 Vascular access, n (%) | |
  Arteriovenous fistula | 568 (94.8) |
  Central tunnelled dialysis catheter | 14 (2.3) |
  Arteriovenous graft | 9 (1.5) |
  Other (temporary catheter) | 8 (1.3) |
 Dialysis frequency, n (%) | |
  Three-times weekly | 513 (85.6) |
  Five times every 2 weeks | 50 (8.3) |
  Twice weekly | 36 (6.0) |
 Dialysate potassium concentration, mmol/L | |
  Mean (SD) | 2.0 (0.14) |
  Median (IQR)c | 2.0 (2.0–2.0) |
 Haemodialysis duration, hours | |
  Mean (SD) | 4.0 (0.16) |